Want to join the conversation?
Medical devices company $COO said its CooperSurgical unit has acquired Genesis Genetics, a genetics laboratory specializing in PGS and PGD used in IVF. The transaction is valued at about $60MM and will be neutral to EPS in FY16 and accretive thereafter. Revenue growth for Genesis Genetics will be in low double digits over the coming years.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.